Abstract
Parkinson disease is a heterogeneous disease with rapidly and slowly progressive forms. Treatment involves pharmacologic approaches (typically with levodopa preparations prescribed with or without other medications) and nonpharmacologic approaches (such as exercise and physical, occupational, and speech therapies). Approaches such as deep brain stimulation and treatment with levodopa-carbidopa enteral suspension can help individuals with medication-resistant tremor, worsening symptoms when the medication wears off, and dyskinesias.
Keywords
MeSH Terms
Affiliated Institutions
Related Publications
Value of combined midbrain sonography, olfactory and motor function assessment in the differential diagnosis of early Parkinson's disease
<sec><st>Objective</st> Characteristic features of Parkinson's disease (PD) are asymmetric parkinsonian motor signs, hyposmia and substantia nigra (SN) hyperec...
Clinically Atypical Expression of Pathologically Typical Lewy-Body Parkinsonism
Six patients autopsied by the neuropathology service at UMDNJ—Robert Wood Johnson Medical School between 1985 and 1988 had pathologically typical Lewy-body Parkinson's disease (...
MDS clinical diagnostic criteria for Parkinson's disease
Abstract This document presents the Movement Disorder Society Clinical Diagnostic Criteria for Parkinson's disease (PD). The Movement Disorder Society PD Criteria are intended f...
Parkinson disease
Parkinson disease (PD) is the most common neurodegenerative movement disorder. In Europe, prevalence and incidence rates for PD are estimated at approximately 108–257/100 000 an...
Low clinical diagnostic accuracy of early vs advanced Parkinson disease
This study provides Class II evidence that a clinical diagnosis of PD identifies patients who will have pathologically confirmed PD with a sensitivity of 88% and specificity of ...
Publication Info
- Year
- 2020
- Type
- review
- Volume
- 323
- Issue
- 6
- Pages
- 548-548
- Citations
- 2518
- Access
- Closed
External Links
Social Impact
Social media, news, blog, policy document mentions
Citation Metrics
Cite This
Identifiers
- DOI
- 10.1001/jama.2019.22360
- PMID
- 32044947